Full Press Release Details
| To Company Name/Scheme | ALTERITY THERAPEUTICS LTD | |
| ACN/ARSN/ ABN | 37 080 699 065 |
1. Details of substantial
| Name | JPMorgan Chase & Co. and its affiliates | |
| ACN/ARSN (if applicable) | NA |
holder became a substantial holder on 11/March/2025
2. Details of voting power
number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an
associate (2) had a relevant interest (3) in on the date the substantial holder became a substantial holder are as follows:
| Class of securities (4) | Number of securities | Person's votes (5) | Voting power (6) |
| Ordinary | 341,554,014 | 341,554,014 | 5.13% |
3. Details of relevant interests
The nature of the relevant interest the substantial holder
or an associate had in the following voting securities on the date the substantial holder became a substantial holder are as follows:
| Holder of relevant interest | Nature of relevant interest (7) | Class and number of securities |
| JPMORGAN CHASE BANK, N.A. | Securities on Loan as Agent Lender | 2,000,000 (Ordinary) |
| J.P. MORGAN SECURITIES LLC | Rehypothecation of client securities under a Prime Brokerage Agreement | 12,178,800 (Ordinary) |
| J.P. MORGAN SECURITIES AUSTRALIA LIMITED | Purchase and sales of securities in its capacity as Principal/Proprietary | 327,343,414 (Ordinary) |
| 55I, LLC | In its capacity as investment manager or in various other related capacities | 31,800 (Ordinary) |
4. Details of present registered holders
The persons registered as holders of the securities referred to in paragraph 3 above are as follows:
| Holder of relevant interest | Registered holder of securities | Person entitled to be registered as holder (8) | Class and number of securities |
| JPMORGAN CHASE BANK, N.A. | JPM Nominees Australia Pty Limited | Various Borrowers under the Securities Lending Agreement | 2,000,000 (Ordinary) |
| J.P. MORGAN SECURITIES LLC | Citi Australia | Various Clients and Custodians | 12,178,800 (Ordinary) |
| J.P. MORGAN SECURITIES AUSTRALIA LIMITED | Ecapital Nominees Pty Ltd | J.P. MORGAN SECURITIES AUSTRALIA LIMITED | 327,343,414 (Ordinary) |
| 55I, LLC | Not Available | Various Clients and Custodians | 31,800 (Ordinary) |
The consideration paid for each relevant interest referred
to in paragraph 3 above, and acquired in the four months prior to the day that the substantial holder became a substantial holder is
| Holder of relevant interest | Date of acquisition | Consideration (9) | Class and number of securities | |
| See Appendix | Cash | Non-cash |
The reasons the persons named in paragraph 3 above are associates
of the substantial holder are as follows:
| Name and ACN/ARSN (if applicable) | Nature of association |
| J.P. MORGAN SECURITIES AUSTRALIA LIMITED | Subsidiary of JPMorgan Chase & Co. |
| 55I, LLC | Subsidiary of JPMorgan Chase & Co. |
| J.P. MORGAN SECURITIES LLC | Subsidiary of JPMorgan Chase & Co. |
| JPMORGAN CHASE BANK, N.A. | Subsidiary of JPMorgan Chase & Co. |
The addresses of persons named in this form are as follows:
| Name | Address |
| JPMorgan Chase & Co. | 383 Madison Avenue, New York, New York, NY, 10179, United States |
| J.P. MORGAN SECURITIES AUSTRALIA LIMITED | LEVEL 18, 83-85 CASTLEREAGH STREET, SYDNEY, NSW 2000, Australia |
| 55I, LLC | One Liberty Square, Suite 200, Boston, Suffolk, MA, 02109, United States |
| J.P. MORGAN SECURITIES LLC | 383 Madison Ave., New York, New York, NY, 10179, United States |
| JPMORGAN CHASE BANK, N.A. | 1111 Polaris Parkway, Columbus, Delaware, OH, 43240, United States |
| Print name | S. Seshagiri Rao | Capacity | Compliance Officer | |
| Sign here | /s/ S. Seshagiri Rao | Date | 13/March/2025 |
See the definition of "relevant agreement" in section
9 of the Corporations Act 2001.
Appendix: Prescribed
information pursuant to securities lending arrangement disclosed under the substantial shareholding notice filed with ASX.
| Date: | 13-March-2025 |
| Company's name: | ALTERITY THERAPEUTICS LTD |
| ISIN: | AU0000043945 |
| Date of change of relevant interests: | 11-March-2025 |
| Schedule | |
| Type of agreement | Global Master Securities Lending Agreement ("GMSLA") |
| Parties to agreement | JPMorgan Chase Bank, N.A. (acting as agent) ("lender") and Morgan Stanley & Co. International PLC (Borrower) |
| Transfer date | Settlement Date 03-Mar-2025 |
| Holder of voting rights | Borrower |
| Are there any restriction on voting rights | Yes |
| If yes, detail | The borrower undertakes to use its best endeavors to arrange for the voting rights to be exercised in accordance with the instructions of the lender, provided that the lender uses its best endeavors to notify the borrower of its instructions in writing no later than 7 business days prior to the date upon which such votes are exercisable or as otherwise agreed between the parties. This undertaking is set out in clause 6.6 of the standard form GMSLA. |
| Scheduled return date (if any) | None |
| Does the borrower have the right to return early? | Yes |
| If yes, detail | Borrower has right to return all and any equivalent securities early at any time in accordance with the lender's instructions. |
| Does the lender have the right to recall early? | Yes |
| If yes, detail | Lender has right to recall all or any equivalent securities at any time by giving notice on any business day of not less than the standard settlement time for such equivalent securities on the exchange or in the clearing organisation through which the relevant borrowed securities were originally delivered (and where there is a difference between the settlement time for sales and purchases on the relevant exchange or clearing organisation, the standard settlement time shall be the shorter of the two times). The borrower must return the securities not later than the expiry of such notice in accordance with the lender's instructions. |
| Will the securities be returned on settlement? | Yes |
| If yes, detail any exceptions | No exceptions |
| Statement | If requested by the company to whom the prescribed form must be given, or if requested by ASIC, a copy of the agreement will be given to that company or ASIC. |